Dr. Rashid Munir is an enthusiastic PhD researcher specializing in multifunctional nanocarriers for the co-delivery of drugs and genes, currently pursuing his doctoral research at Philipps University of Marburg, Germany. His research focuses on developing lipid-based nanocarriers, including liposomes and lipopolyplexes, for enhanced gene therapy and drug delivery in tumor models. He has extensive expertise in nanomedicine formulation, gene and drug delivery systems, and advanced physico-chemical characterization methods such as MTT, pGFP transfection, DLS, and confocal laser scanning microscopy. His technical proficiency extends to polymeric nanoparticles, dual drug–gene delivery systems, and analytical software such as ImageJ, GraphPad Prism, Origin, and Zetasizer Nano. Dr. Munir’s academic foundation includes an MPhil in Pharmaceutics from Quaid-i-Azam University, Islamabad, and a Doctor of Pharmacy (Pharm-D) from the University of Peshawar. He has published two peer-reviewed scientific articles and authored a master’s thesis on targeted drug delivery for rheumatoid arthritis. His research contributions, cited 48 times across 48 documents, demonstrate a growing impact in the fields of nanomedicine and targeted therapeutics, with an h-index of 1. Beyond research, he has served as a Pharmacist at Tianshi International and a Research Assistant at Quaid-i-Azam University, where he gained valuable experience in formulation design, in vitro assays, and academic mentoring. His commitment to innovation and translational research continues to drive advancements in drug delivery, gene therapy, and cancer nanotechnology